Deutsche Bank Ag\ Relmada Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 224,846 shares of RLMD stock, worth $629,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares

224,846

Previous 224,846 -0.0%

Holding current value

$629,568

Previous $674,000 8.01%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.45 - $4.22 $538,723 - $927,923	219,887 Added 4434.1%	224,846 $930,000
Q3 2023 Nov 09, 2023	SELL	$2.48 - $3.79 $578,678 - $884,351	-233,338 Reduced 97.92%	4,959 $14,000
Q2 2023 Aug 14, 2023	SELL	$2.22 - $3.54 $36,507 - $58,215	-16,445 Reduced 6.46%	238,297 $586,000
Q1 2023 May 15, 2023	BUY	$2.24 - $4.76 $34,870 - $74,098	15,567 Added 6.51%	254,742 $575,000
Q4 2022 Feb 13, 2023	BUY	$2.17 - $35.84 $4,055 - $66,984	1,869 Added 0.79%	239,175 $834,000
Q3 2022 Nov 14, 2022	SELL	$18.3 - $37.02 $33,434 - $67,635	-1,827 Reduced 0.76%	237,306 $8.79 Million
Q2 2022 Aug 11, 2022	BUY	$16.5 - $30.34 $9,240 - $16,990	560 Added 0.23%	239,133 $4.54 Million
Q1 2022 May 13, 2022	BUY	$16.72 - $26.99 $3.82 Million - $6.16 Million	228,414 Added 2248.39%	238,573 $6.44 Million
Q4 2021 Feb 11, 2022	SELL	$16.93 - $26.82 $107,031 - $169,556	-6,322 Reduced 38.36%	10,159 $229,000
Q3 2021 Nov 04, 2021	BUY	$21.86 - $34.77 $17,925 - $28,511	820 Added 5.24%	16,481 $432,000
Q2 2021 Aug 11, 2021	SELL	$29.55 - $39.15 $10,549 - $13,976	-357 Reduced 2.23%	15,661 $501,000
Q1 2021 May 13, 2021	BUY	$31.52 - $39.28 $139,034 - $173,264	4,411 Added 38.0%	16,018 $563,000
Q4 2020 Feb 16, 2021	BUY	$29.88 - $39.8 $113,245 - $150,842	3,790 Added 48.48%	11,607 $371,000
Q3 2020 Nov 12, 2020	BUY	$34.42 - $43.78 $23,440 - $29,814	681 Added 9.54%	7,817 $294,000
Q2 2020 Aug 13, 2020	BUY	$31.59 - $49.98 $225,426 - $356,657	7,136 New	7,136 $320,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $80.1M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account